Medical Malpractice Lawyers in AI Search: The Biggest AI Visibility Problems and How We'd Fix Them

Companies covered: Munley Law, Lopez McHugh, Lubin & Meyer, Miller & Zois, Newsome Melton, Paulson & Nace, Morgan & Morgan, The Cochran Firm, Gilman & Bedigian, Pegalis Law Group

Answer Capsule

The November 2026 Medical Malpractice Lawyers benchmark compares 10 companies across 217 AI answers that met its inclusion rules. Morgan & Morgan recorded 204 mentions and 124 recommendations (57.14% of the answers). Being mentioned means appearing in an answer; being recommended means receiving an affirmative endorsement.

We examine each company, compare the available monthly results, and set out a five-step plan for improving the information AI systems can draw on. The work starts with measuring visibility and checking conflicting claims, then moves to company pages, relevant publishers and buyer questions. The cited pages need review before any correction request, and the research does not establish what caused recommendation differences or promise future gains.

Executive industry diagnosis

Questions This Section Answers

• What does the Medical Malpractice Lawyers benchmark show about mentions, recommendations and placement?

This peer set is dominated by one firm. Morgan & Morgan appears in nearly every answer and is recommended in more than half, while every other firm sits far below. The gap is not a small lead to close with modest effort; it is a structural difference in how these answers are written.

The rest of the field splits into two groups. The Cochran Firm and Munley Law are named often enough to be part of the conversation, and Miller & Zois and Lubin & Meyer appear occasionally. Several firms are absent entirely, which is a different problem from being named but not endorsed.

For a client here, the practical question is which group they belong to. A firm already named needs stronger endorsement and better placement; a firm never named needs to understand why before chasing a target. We would treat those as separate workstreams rather than one blended campaign.

What changed since last month

Questions This Section Answers

• What changed across the usable monthly Medical Malpractice Lawyers snapshots?

The monthly figures come from separate answer samples, so they show movement rather than like-for-like performance. Morgan & Morgan's recorded mentions and recommendations both rose in the latest month, and Miller & Zois moved from almost nothing to a visible presence. Munley Law and Lubin & Meyer also recorded more mentions.

The Cochran Firm's mention count eased while its recommendation count edged up, which is a reminder that reach and endorsement can move apart. The firms at zero stayed at zero. The samples differ, so the shifts should be read as observed movement only, not as evidence of what drove them.

Company-by-company findings

Munley Law

Questions This Section Answers

• What measured visibility pattern and review priority does Munley Law have in Medical Malpractice Lawyers?

Munley Law recorded 11 mentions (5.07%) and 9 recommendations (4.15%) across 217 answers included in the benchmark. Top 3 placements numbered 5; first-place recommendations numbered 1. Framing among its mentions was 9 positive, 2 neutral and 0 negative.

From October 2026 to November 2026, Munley Law's mention count rose from 8 to 11, while its recommendation count rose from 6 to 9. The recommendation rate was 3.75% and 4.15% respectively.

AI answers contained 0 conflicting claims about Munley Law: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://munley.com/.

Selected third-party review candidate: https://google.com/searchviewer/10?svid=CAwSHRIbCgNwdnESFENnMHZaeTh4TVhaemNEVm9lRzE0GAo.

Munley Law is named often enough to be a recognized option, and most of those mentions carry positive wording. The weak point is position: it rarely takes the top slot, so it is present in the conversation without being the answer. We would propose a page brief for the owned candidate and a buyer-question content set aimed at the questions where it already appears, with facts verified against current primary sources before any edit.

Lopez McHugh

Questions This Section Answers

• What measured visibility pattern and review priority does Lopez McHugh have in Medical Malpractice Lawyers?

Lopez McHugh recorded 0 mentions (0.00%) and 0 recommendations (0.00%) across 217 answers included in the benchmark. Top 3 placements numbered 0; first-place recommendations numbered 0. Framing among its mentions was 0 positive, 0 neutral and 0 negative.

From October 2026 to November 2026, Lopez McHugh's mention count stayed at 0, while its recommendation count stayed at 0. The recommendation rate was 0.00% and 0.00% respectively.

AI answers contained 0 conflicting claims about Lopez McHugh: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

No results are available for this part of the analysis.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Lopez McHugh does not appear in the recorded answers at all, so there is no endorsement gap to close yet. The first task is understanding why: whether the firm is being matched to these questions, whether its public material is being read, or whether the answers simply favor larger national names. We would propose a scoped review of the firm's owned pages and a small set of buyer-question briefs, treating any visibility target as premature until that review is complete.

Lubin & Meyer

Questions This Section Answers

• What measured visibility pattern and review priority does Lubin & Meyer have in Medical Malpractice Lawyers?

Lubin & Meyer recorded 6 mentions (2.76%) and 4 recommendations (1.84%) across 217 answers included in the benchmark. Top 3 placements numbered 4; first-place recommendations numbered 2. Framing among its mentions was 4 positive, 2 neutral and 0 negative.

From October 2026 to November 2026, Lubin & Meyer's mention count rose from 3 to 6, while its recommendation count rose from 3 to 4. The recommendation rate was 1.88% and 1.84% respectively.

AI answers contained 0 conflicting claims about Lubin & Meyer: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://lubinandmeyer.com/news/best-law-firms.html.

Selected third-party review candidate: https://google.com/searchviewer/10?svid=CAwSHRIbCgNwdnESFENnMHZaeTh4TVdNMk1ETTNhakptGAo.

Lubin & Meyer is a small but real presence, and its mentions are mostly positive. Its placements are relatively strong when it does appear, which suggests the issue is frequency rather than standing. We would propose a page brief for the owned candidate and a fact-check pass on the third-party page, confirming current contents before any request is made.

Miller & Zois

Questions This Section Answers

• What measured visibility pattern and review priority does Miller & Zois have in Medical Malpractice Lawyers?

Miller & Zois recorded 12 mentions (5.53%) and 4 recommendations (1.84%) across 217 answers included in the benchmark. Top 3 placements numbered 3; first-place recommendations numbered 0. Framing among its mentions was 4 positive, 8 neutral and 0 negative.

From October 2026 to November 2026, Miller & Zois' mention count rose from 1 to 12, while its recommendation count rose from 0 to 4. The recommendation rate was 0.00% and 1.84% respectively.

AI answers contained 0 conflicting claims about Miller & Zois: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://millerandzois.com/settlement-value-your-claim/.

Selected third-party review candidate: https://chglawyers.com/catastrophic-injury/injury-compensation-chart/.

Miller & Zois is named more often than several peers but is recommended far less often, and it holds no first-place position. That pattern points to reach without endorsement: the firm is listed, but the answers do not affirmatively favor it. We would propose a page brief for the settlement-value page and a review of the third-party compensation chart, verifying both before recommending changes.

Newsome Melton

Questions This Section Answers

• What measured visibility pattern and review priority does Newsome Melton have in Medical Malpractice Lawyers?

Newsome Melton recorded 0 mentions (0.00%) and 0 recommendations (0.00%) across 217 answers included in the benchmark. Top 3 placements numbered 0; first-place recommendations numbered 0. Framing among its mentions was 0 positive, 0 neutral and 0 negative.

From October 2026 to November 2026, Newsome Melton's mention count stayed at 0, while its recommendation count stayed at 0. The recommendation rate was 0.00% and 0.00% respectively.

AI answers contained 0 conflicting claims about Newsome Melton: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

No results are available for this part of the analysis.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Newsome Melton is absent from the recorded answers, so there is no recommendation pattern to interpret. Before setting any target, we would want to know whether the firm is being considered at all in these answers and what public material the answers draw on. We would propose a scoped owned-page review and a short set of buyer-question briefs, with any visibility goal deferred until that baseline exists.

Paulson & Nace

Questions This Section Answers

• What measured visibility pattern and review priority does Paulson & Nace have in Medical Malpractice Lawyers?

Paulson & Nace recorded 0 mentions (0.00%) and 0 recommendations (0.00%) across 217 answers included in the benchmark. Top 3 placements numbered 0; first-place recommendations numbered 0. Framing among its mentions was 0 positive, 0 neutral and 0 negative.

From October 2026 to November 2026, Paulson & Nace's mention count stayed at 0, while its recommendation count stayed at 0. The recommendation rate was 0.00% and 0.00% respectively.

AI answers contained 0 conflicting claims about Paulson & Nace: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

No results are available for this part of the analysis.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Paulson & Nace does not appear in the recorded answers, which means the current task is diagnosis rather than optimization. The absence could reflect how the firm is described publicly, how these particular questions are phrased, or simply the weight of larger national names. We would propose a scoped review of owned pages and a buyer-question brief set, and hold off on any performance target until the review is done.

Morgan & Morgan

Questions This Section Answers

• What measured visibility pattern and review priority does Morgan & Morgan have in Medical Malpractice Lawyers?

Morgan & Morgan recorded 204 mentions (94.01%) and 124 recommendations (57.14%) across 217 answers included in the benchmark. Top 3 placements numbered 92; first-place recommendations numbered 66. Framing among its mentions was 171 positive, 33 neutral and 0 negative.

From October 2026 to November 2026, Morgan & Morgan's mention count rose from 154 to 204, while its recommendation count rose from 85 to 124. The recommendation rate was 53.13% and 57.14% respectively.

AI answers contained 65 conflicting claims about Morgan & Morgan: 0 critical, 8 high, 42 medium, 15 low. Of these, 8 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://forthepeople.com/.

Selected third-party review candidate: https://en.wikipedia.org/wiki/Morgan_%26_Morgan.

Morgan & Morgan is the reference point for this peer set, appearing in almost every answer and recommended in most. That reach also brings scrutiny: the recorded answers contain conflicting claims about the firm, including a high-priority dispute over who was sanctioned in AI case-law matters. We would propose a fact-check register for those claims, a page brief for the owned candidate and a review of the Wikipedia entry, with corrections only after primary-source verification.

The Cochran Firm

Questions This Section Answers

• What measured visibility pattern and review priority does The Cochran Firm have in Medical Malpractice Lawyers?

The Cochran Firm recorded 20 mentions (9.22%) and 18 recommendations (8.29%) across 217 answers included in the benchmark. Top 3 placements numbered 15; first-place recommendations numbered 0. Framing among its mentions was 18 positive, 2 neutral and 0 negative.

From October 2026 to November 2026, The Cochran Firm's mention count fell from 23 to 20, while its recommendation count rose from 17 to 18. The recommendation rate was 10.63% and 8.29% respectively.

AI answers contained 0 conflicting claims about The Cochran Firm: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://cochranfirm.com/medical-malpractice/are-small-damage-cases-worth-pursuing/.

Selected third-party review candidate: https://fusionlegalgroup.com/top-10-personal-injury-law-firms/.

The Cochran Firm is recommended nearly as often as it is mentioned, which is a strong endorsement pattern, but it never takes first place. That combination suggests the answers treat it as a credible alternative rather than the leading choice. We would propose a page brief for the owned candidate and a review of the third-party top-firms list, verifying current contents before any request.

Gilman & Bedigian

Questions This Section Answers

• What measured visibility pattern and review priority does Gilman & Bedigian have in Medical Malpractice Lawyers?

Gilman & Bedigian recorded 1 mentions (0.46%) and 1 recommendation (0.46%) across 217 answers included in the benchmark. Top 3 placements numbered 0; first-place recommendations numbered 0. Framing among its mentions was 1 positive, 0 neutral and 0 negative.

From October 2026 to November 2026, Gilman & Bedigian's mention count rose from 0 to 1, while its recommendation count rose from 0 to 1. The recommendation rate was 0.00% and 0.46% respectively.

AI answers contained 0 conflicting claims about Gilman & Bedigian: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://gilmanbedigian.com/costs-in-medical-malpractice-cases/.

Selected third-party review candidate: https://arfaalawgroup.com/medical-negligence-and-personal-injury/medical-malpractice/other-malpractice/dental-malpractice/.

Gilman & Bedigian appears once and that single mention is a recommendation, so the pattern is too thin to interpret as a trend. The useful next step is understanding which question produced it and whether the firm's material supports broader coverage. We would propose a page brief for the costs page and a review of the third-party dental malpractice page, both conditional on verifying current contents.

Pegalis Law Group

Questions This Section Answers

• What measured visibility pattern and review priority does Pegalis Law Group have in Medical Malpractice Lawyers?

Pegalis Law Group recorded 0 mentions (0.00%) and 0 recommendations (0.00%) across 217 answers included in the benchmark. Top 3 placements numbered 0; first-place recommendations numbered 0. Framing among its mentions was 0 positive, 0 neutral and 0 negative.

From October 2026 to November 2026, Pegalis Law Group's mention count stayed at 0, while its recommendation count stayed at 0. The recommendation rate was 0.00% and 0.00% respectively.

AI answers contained 0 conflicting claims about Pegalis Law Group: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

No results are available for this part of the analysis.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Pegalis Law Group does not appear in the recorded answers, so there is no endorsement pattern to work from. The absence may reflect how the firm is described publicly or how these questions are framed, and we would not assume either. We would propose a scoped owned-page review and a small buyer-question brief set, deferring any visibility target until that review establishes a baseline.

The CiteWorks five-step improvement plan

Step 1. Establish the baseline

Questions This Section Answers

• What should the agency deliver when it works to establish the baseline for Medical Malpractice Lawyers?

We would build a scorecard that records each firm's mentions, recommendations and placements exactly as measured, with the sample size and month attached to every row. The point is a traceable record the client can compare against later, not a ranking to celebrate.

We would also document what makes future months comparable: which questions were asked, which services were covered and how inclusion rules were applied. Without that, next month's numbers invite conclusions the data cannot support.

Step 2. Verify disputed facts

Questions This Section Answers

• What should the agency deliver when it works to verify disputed facts for Medical Malpractice Lawyers?

AI answers contained 65 conflicting claims across 1 companies. Another 0 possible conflicts were excluded because their company matches were uncertain. The conflicting claims need fact-checking before any corrections are proposed.

The recorded answers contain conflicting claims concentrated in one firm, with a smaller number rated high priority. Those need checking against current primary sources before anyone proposes a correction, because an apparent conflict can dissolve once dates and entities are resolved.

We would keep a register that records each disputed claim, the evidence required and the outcome. Claims tied to uncertain company matches stay out of the correction queue entirely, and a confirmed conflict does not by itself prove that a publisher or the company made an error.

Step 3. Review owned pages

Questions This Section Answers

• What should the agency deliver when it works to review owned pages for Medical Malpractice Lawyers?

We would assign page briefs to the owned pages already selected for review, one per firm, each stating what the page should establish for a buyer and which facts must be verified first. The briefs are proposals, not findings about what those pages currently say.

Before any edit, we would confirm the page's current contents and the underlying facts from primary sources. Where verification fails or the page is not the right vehicle, the brief records a no-change decision rather than forcing an edit.

Step 4. Review third-party sources

Questions This Section Answers

• What should the agency deliver when it works to review third-party sources for Medical Malpractice Lawyers?

For the third-party pages already linked, we would prepare review packages that state what the page currently says, which claims matter and what evidence would support a request. Citation appearances alone do not show that a source influenced an answer, so we would not treat them as leverage.

Requests would go out only after verification, and we would log responses separately from confirmed edits. Some pages will warrant no request at all, and that outcome should be recorded as a decision rather than a failure.

Step 5. Address buyer questions and measure again

Questions This Section Answers

• What should the agency deliver when it works to address buyer questions and measure again for Medical Malpractice Lawyers?

The observed questions give us a starting point for buyer-facing content briefs, particularly where a firm already appears in answers. We would draft briefs around those questions and route them through the same fact-checking discipline as page work.

Measurement would follow separately. We would record what work was delivered and then take a fresh scorecard, keeping delivered work distinct from answer outcomes so that no one mistakes activity for improvement.

Third-party authority and citation opportunities

Questions This Section Answers

• Which cited publisher pages support targeted source review in Medical Malpractice Lawyers?

These pages are candidates for review, not confirmed errors. Citation appearances are counted across the captured answers and are not added again for each company.

The linked publishers vary widely in how often they appear across captured answers, and the most-cited page covers a single dominant firm. That concentration means a review of that page matters for one client but does little for the rest of the field.

We would prioritize by relevance to the client's own questions first, then by how often the page appears. Before any request, we would verify what the page currently says and whether the cited claims are accurate; citation counts are not evidence of influence, and these pages are candidates for review, not confirmed errors.

What we'd prioritize first

The first priority is the fact-check register for the firm with disputed claims, because those conflicts affect how that firm is described and carry the highest severity. The second is the scorecard and comparability record, which everything else depends on.

After that, page briefs for the firms already appearing in answers offer the clearest path to stronger endorsement, while the absent firms need diagnostic reviews before any target is set. Publisher requests come last, once verification is complete and the pages have been read.

Methodology and conclusion

Questions This Section Answers

• What do the Medical Malpractice Lawyers sample and source-review limits allow us to conclude?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 217 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 695 captured answers and 3591 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

The answer samples differ between months. These comparisons show how the recorded results changed; they do not establish why they changed.

These results describe how a fixed set of answers discussed this peer set in the reporting month. The samples differ between months, so month-to-month movement shows what was recorded, not why it changed, and the counts cannot be added across firms because one answer can name several.

Recommendations require affirmative endorsement, and placements sit inside recommendations rather than alongside them. The proposed work is a starting plan: scorecards, fact checks, page briefs, publisher reviews and buyer-question content, each conditional on verification. We make no promise that any of it will change future answers.